{
    "clinical_study": {
        "@rank": "26656", 
        "arm_group": [
            {
                "arm_group_label": "nonivamide + nicoboxil (Finalgon)", 
                "arm_group_type": "Active Comparator", 
                "description": "2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period"
            }, 
            {
                "arm_group_label": "nonivamide", 
                "arm_group_type": "Active Comparator", 
                "description": "2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period"
            }, 
            {
                "arm_group_label": "nicoboxil", 
                "arm_group_type": "Active Comparator", 
                "description": "2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period"
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to assess the efficacy and tolerability of Nicoboxil/Nonivamide\n      ointment in comparison to Nicoboxil, Nonivamide, and placebo ointments for the treatment of\n      acute low back pain."
        }, 
        "brief_title": "Nonivamide/Nicoboxil Ointment in Acute Low Back Pain", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "Patients treated with placebo ointment", 
                            "title": "Placebo"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "Patients treated with ointments containing 2.5% nicoboxil alone", 
                            "title": "Nicoboxil"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Patients treated with ointments containing 0.4% nonivamide alone", 
                            "title": "Nonivamide"
                        }, 
                        {
                            "@group_id": "B4", 
                            "description": "Patients treated with ointments containing a combination of 2.5% nicoboxil and 0.4% nonivamide", 
                            "title": "Nicoboxil/Nonivamide"
                        }, 
                        {
                            "@group_id": "B5", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "204"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "201"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "198"
                                            }, 
                                            {
                                                "@group_id": "B4", 
                                                "@value": "202"
                                            }, 
                                            {
                                                "@group_id": "B5", 
                                                "@value": "805"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "13.27", 
                                                "@value": "39.2"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "13.06", 
                                                "@value": "40.4"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "13.53", 
                                                "@value": "42.2"
                                            }, 
                                            {
                                                "@group_id": "B4", 
                                                "@spread": "14.31", 
                                                "@value": "40.2"
                                            }, 
                                            {
                                                "@group_id": "B5", 
                                                "@spread": "13.57", 
                                                "@value": "40.5"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "94"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "91"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "103"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "100"
                                                }, 
                                                {
                                                    "@group_id": "B5", 
                                                    "@value": "388"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "110"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "110"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "95"
                                                }, 
                                                {
                                                    "@group_id": "B4", 
                                                    "@value": "102"
                                                }, 
                                                {
                                                    "@group_id": "B5", 
                                                    "@value": "417"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }
                    ]
                }, 
                "population": "Patients from Treated Set (TS): Patients who were randomised and who used at least 1 dose of study medication."
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-1.699", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-1.025", 
                                    "dispersion_type": "Standard Error of the mean", 
                                    "dispersion_value": "0.171", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O4"
                                        ]
                                    }, 
                                    "method": "Restricted Maximum Likelihood (REML)", 
                                    "method_desc": "REML based on Repeated Measures Model, using all Available Longitudinal Pain Intensity Observations at each Post-baseline time up to 8 hours.", 
                                    "non_inferiority": "No", 
                                    "p_value": "<0.0001", 
                                    "p_value_desc": "Model included the fixed, categorical effects of treatment, centre, time, treatment-by-time interaction and the continuous covariate of baseline PI.", 
                                    "param_type": "Mean Difference (Final Values)", 
                                    "param_value": "-1.362"
                                }, 
                                {
                                    "ci_lower_limit": "-1.324", 
                                    "ci_n_sides": "2-Sided", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-0.642", 
                                    "dispersion_type": "Standard Error of the mean", 
                                    "dispersion_value": "0.173", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O4"
                                        ]
                                    }, 
                                    "method": "Restricted Maximum Likelihood (REML)", 
                                    "method_desc": "REML based on Repeated Measures Model, using all Available Longitudinal Pain Intensity Observations at each Post-baseline time up to 8 hours.", 
                                    "non_inferiority": "No", 
                                    "p_value": "<0.0001", 
                                    "p_value_desc": "Model included the fixed, categorical effects of treatment, centre, time, treatment-by-time interaction and the continuous covariate of baseline PI.", 
                                    "param_type": "Mean Difference (Final Values)", 
                                    "param_value": "-0.983"
                                }, 
                                {
                                    "ci_lower_limit": "-0.541", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "0.225", 
                                    "dispersion_type": "Standard Error of the mean", 
                                    "dispersion_value": "0.195", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O3", 
                                            "O4"
                                        ]
                                    }, 
                                    "method": "Restricted Maximum Likelihood (REML)", 
                                    "method_desc": "REML based on Repeated Measures Model, using all Available Longitudinal Pain Intensity Observations at each Post-baseline time up to 8 hours.", 
                                    "non_inferiority": "No", 
                                    "p_value": "0.4171", 
                                    "p_value_desc": "Model included the fixed, categorical effects of treatment, centre, time, treatment-by-time interaction and the continuous covariate of baseline PI.", 
                                    "param_type": "Mean Difference (Final Values)", 
                                    "param_value": "-0.158"
                                }
                            ]
                        }, 
                        "description": "Pain intensity (PI) was assessed on a 11-point numerical rating scale ranging from 0 (no pain) to 10 (worst pain possible) at pre-dose baseline and 0.5, 1, 2, 3, 4, 6 and 8 hours after first ointment application. Means were adjusted for centre effect and baseline value.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Patients treated with placebo ointment", 
                                    "title": "Placebo"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Patients treated with ointments containing 2.5% nicoboxil alone", 
                                    "title": "Nicoboxil"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Patients treated with ointments containing 0.4% nonivamide alone", 
                                    "title": "Nonivamide"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "Patients treated with ointments containing a combination of 2.5% nicoboxil and 0.4% nonivamide", 
                                    "title": "Nicoboxil/Nonivamide"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "204"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "201"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "198"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "202"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.106", 
                                                        "@value": "-1.049"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "0.109", 
                                                        "@value": "-1.428"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "0.141", 
                                                        "@value": "-2.252"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@spread": "0.138", 
                                                        "@value": "-2.410"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Pain intensity (PI) was assessed on a 11-point numerical rating scale ranging from 0 (no pain) to 10 (worst pain possible) at pre-dose baseline and 0.5, 1, 2, 3, 4, 6 and 8 hours after first ointment application. Means were adjusted for centre effect and baseline value.", 
                                    "dispersion": "Standard Error", 
                                    "param": "Least Squares Mean", 
                                    "title": "Pain Intensity Difference (PID) Between Pre-dose Baseline and 8hours After First Application", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "Patients from the Full Analysis Set (FAS): all randomised patients who used at least 1 dose of study medication and provided any post-treatment data for the pain intensity difference within 8 hours after first application.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and 8 hours after first ointment application", 
                        "title": "Pain Intensity Difference (PID) Between Pre-dose Baseline and 8hours After First Application", 
                        "type": "Primary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-1.305", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-0.793", 
                                    "dispersion_type": "Standard Error of the mean", 
                                    "dispersion_value": "0.130", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O4"
                                        ]
                                    }, 
                                    "method": "Restricted Maximum Likelihood (REML)", 
                                    "method_desc": "REML based on Repeated Measures Model, using all Available Longitudinal Pain Intensity Observations at each Post-baseline time up to 8 hours.", 
                                    "non_inferiority": "No", 
                                    "p_value": "<0.0001", 
                                    "p_value_desc": "Model included the fixed, categorical effects of treatment, centre, time, treatment-by-time interaction and the continuous covariate of baseline PI.", 
                                    "param_type": "Mean Difference (Final Values)", 
                                    "param_value": "-1.049"
                                }, 
                                {
                                    "ci_lower_limit": "-1.003", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-0.459", 
                                    "dispersion_type": "Standard Error of the mean", 
                                    "dispersion_value": "0.138", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O4"
                                        ]
                                    }, 
                                    "method": "Restricted Maximum Likelihood (REML)", 
                                    "method_desc": "REML based on Repeated Measures Model, using all Available Longitudinal Pain Intensity Observations at each Post-baseline time up to 8 hours.", 
                                    "non_inferiority": "No", 
                                    "p_value": "<0.0001", 
                                    "p_value_desc": "Model included the fixed, categorical effects of treatment, centre, time, treatment-by-time interaction and the continuous covariate of baseline PI.", 
                                    "param_type": "Mean Difference (Final Values)", 
                                    "param_value": "-0.731"
                                }, 
                                {
                                    "ci_lower_limit": "-0.356", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "0.241", 
                                    "dispersion_type": "Standard Error of the mean", 
                                    "dispersion_value": "0.152", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O3", 
                                            "O4"
                                        ]
                                    }, 
                                    "method": "Restricted Maximum Likelihood (REML)", 
                                    "method_desc": "REML based on Repeated Measures Model, using all Available Longitudinal Pain Intensity Observations at each Post-baseline time up to 8 hours.", 
                                    "non_inferiority": "No", 
                                    "p_value": "0.7037", 
                                    "p_value_desc": "Model included the fixed, categorical effects of treatment, centre, time, treatment-by-time interaction and the continuous covariate of baseline PI.", 
                                    "param_type": "Mean Difference (Final Values)", 
                                    "param_value": "-0.058"
                                }
                            ]
                        }, 
                        "description": "Pain intensity was assessed on a 11-point numerical rating scale ranging from 0 (no pain) to 10 (worst pain possible) at pre-dose baseline and 0.5, 1, 2, 3 and 4 hours after first ointment application. Means were adjusted for centre effect and baseline value.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Patients treated with placebo ointment", 
                                    "title": "Placebo"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Patients treated with ointments containing 2.5% nicoboxil alone", 
                                    "title": "Nicoboxil"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Patients treated with ointments containing 0.4% nonivamide alone", 
                                    "title": "Nonivamide"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "Patients treated with ointments containing a combination of 2.5% nicoboxil and 0.4% nonivamide", 
                                    "title": "Nicoboxil/Nonivamide"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "204"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "201"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "198"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "202"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.077", 
                                                        "@value": "-0.650"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "0.091", 
                                                        "@value": "-0.968"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "0.110", 
                                                        "@value": "-1.641"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@spread": "0.109", 
                                                        "@value": "-1.699"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Pain intensity was assessed on a 11-point numerical rating scale ranging from 0 (no pain) to 10 (worst pain possible) at pre-dose baseline and 0.5, 1, 2, 3 and 4 hours after first ointment application. Means were adjusted for centre effect and baseline value.", 
                                    "dispersion": "Standard Error", 
                                    "param": "Least Squares Mean", 
                                    "title": "Pain Intensity Difference (PID) Between Pre-dose Baseline and 4 Hours After First Application", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "Patients from FAS.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and 4 hours after first ointment application", 
                        "title": "Pain Intensity Difference (PID) Between Pre-dose Baseline and 4 Hours After First Application", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "-2.064", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-1.247", 
                                    "dispersion_type": "Standard Error of the mean", 
                                    "dispersion_value": "0.208", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O4"
                                        ]
                                    }, 
                                    "method": "ANCOVA", 
                                    "method_desc": "The statistical model included baseline PI, centre, and treatment.", 
                                    "non_inferiority": "No", 
                                    "p_value": "<0.0001", 
                                    "param_type": "Mean Difference (Final Values)", 
                                    "param_value": "-1.655"
                                }, 
                                {
                                    "ci_lower_limit": "-1.578", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-0.759", 
                                    "dispersion_type": "Standard Error of the mean", 
                                    "dispersion_value": "0.209", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O4"
                                        ]
                                    }, 
                                    "method": "ANCOVA", 
                                    "method_desc": "The statistical model included baseline PI, centre, and treatment.", 
                                    "non_inferiority": "No", 
                                    "p_value": "<0.0001", 
                                    "param_type": "Mean Difference (Final Values)", 
                                    "param_value": "-1.169"
                                }, 
                                {
                                    "ci_lower_limit": "-0.875", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "-0.056", 
                                    "dispersion_type": "Standard Error of the mean", 
                                    "dispersion_value": "0.209", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O3", 
                                            "O4"
                                        ]
                                    }, 
                                    "method": "ANCOVA", 
                                    "method_desc": "The statistical model included baseline PI, centre, and treatment.", 
                                    "non_inferiority": "No", 
                                    "p_value": "0.0259", 
                                    "param_type": "Mean Difference (Final Values)", 
                                    "param_value": "-0.466"
                                }
                            ]
                        }, 
                        "description": "Average pain intensity was assessed in the evening of days 1, 2, 3 and 4 on a 11-point numerical rating scale ranging from 0 (no pain) to 10 (worst pain possible). The last individual treatment day is the last day with diary-recorded ointment application. Means were adjusted for centre effect and baseline value.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Patients treated with placebo ointment", 
                                    "title": "Placebo"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Patients treated with ointments containing 2.5% nicoboxil alone", 
                                    "title": "Nicoboxil"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Patients treated with ointments containing 0.4% nonivamide alone", 
                                    "title": "Nonivamide"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "Patients treated with ointments containing a combination of 2.5% nicoboxil and 0.4% nonivamide", 
                                    "title": "Nicoboxil/Nonivamide"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "200"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "200"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "198"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "199"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.160", 
                                                        "@value": "-1.884"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "0.160", 
                                                        "@value": "-2.371"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "0.161", 
                                                        "@value": "-3.074"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@spread": "0.159", 
                                                        "@value": "-3.540"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Average pain intensity was assessed in the evening of days 1, 2, 3 and 4 on a 11-point numerical rating scale ranging from 0 (no pain) to 10 (worst pain possible). The last individual treatment day is the last day with diary-recorded ointment application. Means were adjusted for centre effect and baseline value.", 
                                    "dispersion": "Standard Error", 
                                    "param": "Least Squares Mean", 
                                    "title": "Difference Between Baseline Pain Intensity and Average Pain Intensity on the Last Individual Treatment Day", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "Patients from FAS with evaluable data for the pain intensity at baseline and for the avarage pain intensity on the last individual treatment day.", 
                        "safety_issue": "No", 
                        "time_frame": "Baseline and 1 to 4 days", 
                        "title": "Difference Between Baseline Pain Intensity and Average Pain Intensity on the Last Individual Treatment Day", 
                        "type": "Secondary"
                    }, 
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "ci_lower_limit": "4.943", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "11.032", 
                                    "estimate_desc": "Odds Ratio was calculated by Nicoboxil/Nonivamide : Placebo. Odds ratios > 1 favour Nicoboxil/Nonivamide.", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O4"
                                        ]
                                    }, 
                                    "method": "Regression, Logistic", 
                                    "method_desc": "The logistic regression model included baseline PI, centre, and treatment.", 
                                    "non_inferiority": "No", 
                                    "p_value": "<0.0001", 
                                    "param_type": "Odds Ratio (OR)", 
                                    "param_value": "7.385"
                                }, 
                                {
                                    "ci_lower_limit": "2.469", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "5.308", 
                                    "estimate_desc": "Odds Ratio was calculated by Nicoboxil/Nonivamide : Nicoboxil. Odds ratios > 1 favour Nicoboxil/Nonivamide.", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O4"
                                        ]
                                    }, 
                                    "method": "Regression, Logistic", 
                                    "method_desc": "The logistic regression model included baseline PI, centre, and treatment.", 
                                    "non_inferiority": "No", 
                                    "p_value": "<0.0001", 
                                    "param_type": "Odds Ratio (OR)", 
                                    "param_value": "3.620"
                                }, 
                                {
                                    "ci_lower_limit": "1.104", 
                                    "ci_percent": "95", 
                                    "ci_upper_limit": "2.303", 
                                    "estimate_desc": "Odds Ratio was calculated by Nicoboxil/Nonivamide : Nonivamide. Odds ratios > 1 favour Nicoboxil/Nonivamide.", 
                                    "group_id_list": {
                                        "group_id": [
                                            "O3", 
                                            "O4"
                                        ]
                                    }, 
                                    "method": "Regression, Logistic", 
                                    "method_desc": "The logistic regression model included baseline PI, centre, and treatment.", 
                                    "non_inferiority": "No", 
                                    "p_value": "0.0129", 
                                    "param_type": "Odds Ratio (OR)", 
                                    "param_value": "1.594"
                                }
                            ]
                        }, 
                        "description": "Patient assessment of efficacy was assessed on a 4-point verbal rating scale (VRS, 0 = 'poor', 1 = 'fair', 2 = 'good', 3 = 'very good' relief of the patients' low back pain) in the evening of days 1, 2, 3 and 4. The last individual treatment day is the last day with diary-recorded ointment application", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Patients treated with placebo ointment", 
                                    "title": "Placebo"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Patients treated with ointments containing 2.5% nicoboxil alone", 
                                    "title": "Nicoboxil"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Patients treated with ointments containing 0.4% nonivamide alone", 
                                    "title": "Nonivamide"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "Patients treated with ointments containing a combination of 2.5% nicoboxil and 0.4% nonivamide", 
                                    "title": "Nicoboxil/Nonivamide"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "204"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "201"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "198"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "202"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "0.160", 
                                                            "@value": "9"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "0.160", 
                                                            "@value": "19"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@spread": "0.161", 
                                                            "@value": "34"
                                                        }, 
                                                        {
                                                            "@group_id": "O4", 
                                                            "@spread": "0.159", 
                                                            "@value": "50"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Very good"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "47"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "67"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "85"
                                                        }, 
                                                        {
                                                            "@group_id": "O4", 
                                                            "@value": "88"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Good"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "22"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "20"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "27"
                                                        }, 
                                                        {
                                                            "@group_id": "O4", 
                                                            "@value": "20"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Fair"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "125"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "94"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "52"
                                                        }, 
                                                        {
                                                            "@group_id": "O4", 
                                                            "@value": "42"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Poor"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O3", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O4", 
                                                            "@value": "2"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Missing"
                                            }
                                        ]
                                    }, 
                                    "description": "Patient assessment of efficacy was assessed on a 4-point verbal rating scale (VRS, 0 = 'poor', 1 = 'fair', 2 = 'good', 3 = 'very good' relief of the patients' low back pain) in the evening of days 1, 2, 3 and 4. The last individual treatment day is the last day with diary-recorded ointment application", 
                                    "param": "Number", 
                                    "title": "Patient Assessment of Efficacy on the Last Individual Treatment Day", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "population": "Patients from FAS.", 
                        "safety_issue": "No", 
                        "time_frame": "1 to 4 days", 
                        "title": "Patient Assessment of Efficacy on the Last Individual Treatment Day", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Patients treated with placebo ointment", 
                            "title": "Placebo"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "Patients treated with ointments containing 2.5% nicoboxil alone", 
                            "title": "Nicoboxil"
                        }, 
                        {
                            "@group_id": "P3", 
                            "description": "Patients treated with ointments containing 0.4% nonivamide alone", 
                            "title": "Nonivamide"
                        }, 
                        {
                            "@group_id": "P4", 
                            "description": "Patients treated with ointments containing a combination of 2.5% nicoboxil and 0.4% nonivamide", 
                            "title": "Nicoboxil/Nonivamide"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "1", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "9", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "13", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Adverse Event"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "84", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "60", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "35", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "15", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Lack of Efficacy"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Protocol Violation"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "2", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "2", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Withdrawal by Subject"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "1", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "2", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "Other reasons than stated above"
                                }
                            ]
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "204", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "201", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "198", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "202", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "118", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "139", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "152", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "169", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "86", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "62", 
                                                "@group_id": "P2"
                                            }, 
                                            {
                                                "@count": "46", 
                                                "@group_id": "P3"
                                            }, 
                                            {
                                                "@count": "33", 
                                                "@group_id": "P4"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "email": "clintriage.rdg@boehringer-ingelheim.com", 
                "name_or_title": "Boehringer Ingelheim Call Center", 
                "organization": "Boehringer Ingelheim Pharmaceuticals", 
                "phone": "1-800-243-0127"
            }, 
            "reported_events": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "Patients treated with placebo ointment", 
                            "title": "Placebo"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "Patients treated with ointments containing 2.5% nicoboxil alone", 
                            "title": "Nicoboxil"
                        }, 
                        {
                            "@group_id": "E3", 
                            "description": "Patients treated with ointments containing 0.4% nonivamide alone", 
                            "title": "Nonivamide"
                        }, 
                        {
                            "@group_id": "E4", 
                            "description": "Patients treated with ointments containing a combination of 2.5% nicoboxil and 0.4% nonivamide alone", 
                            "title": "Nicoboxil/Nonivamide"
                        }
                    ]
                }, 
                "serious_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "204"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "201"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "198"
                                            }, 
                                            {
                                                "@group_id": "E4", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "202"
                                            }
                                        ], 
                                        "sub_title": "Total, serious adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "assessment": "Systematic Assessment", 
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "204"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "201"
                                            }, 
                                            {
                                                "@group_id": "E3", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "198"
                                            }, 
                                            {
                                                "@group_id": "E4", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "202"
                                            }
                                        ], 
                                        "sub_title": "Back pain"
                                    }
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Non-systematic Assessment", 
                    "default_vocab": "MEDDRA 16.0"
                }, 
                "time_frame": "Up to 4 days"
            }
        }, 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Acute Low Back Pain", 
        "condition_browse": {
            "mesh_term": [
                "Back Pain", 
                "Low Back Pain"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  Patients must sign and date an Informed Consent consistent with International\n             Conference on Hermonisation (ICH)/Good Clinical Practice (GCP) guidelines and local\n             regulation prior to participation in the trial.\n\n          -  Patients must agree to cooperate with all trial evaluations and perform all required\n             tasks.\n\n          -  Acute low back pain for more than 2 days and less than 21 days (= 3 weeks)\n\n          -  Male or female patients aged 18 to 65 years\n\n          -  Low back pain rating >5 on a 0-10 numerical rating scale (NRS).\n\n          -  Female patients of childbearing potential may participate only in case of\n             availability of a negative urine pregnancy test and a confirmed menstrual period\n             prior to study entry and using a highly effective method of birth control. Highly\n             effective methods of birth control are defined as those which result in a low failure\n             rate (i.e. less than 1 % per year) when used consistently and correctly such as\n             implants, injectables, combined oral contraceptives, appropriate intrauterine\n             devices, sexual abstinence or vasectomised partner. Barrier methods of contraception\n             (e.g. condom, diaphragma or occlusive cap) are accepted if used in combination with\n             spermicides (e.g. foam, gel). Female patients will be considered being of\n             childbearing potential unless surgically sterilised by bilateral tubal\n             ligation/salpingectomy or hysterectomy or post-menopausal for at least one year.\n\n        Exclusion criteria:\n\n          -  Multilocular pain or panalgesia\n\n          -  History of more than three low back pain episodes in the last six months\n\n          -  Abnormal findings in at least one of the following assessments: Achilles tendon\n             reflex, patella reflex, heel walking, toe walking, cutaneous sensitivity of the legs\n             (including gluteal region), paresis tests in supine position upon dorsiflexion,\n             plantarflexion, hip flexion, knee extension\n\n          -  Bladder and/or rectum dysfunction\n\n          -  Acute low back pain due to vertebral collapse or neoplastic, inflammatory (ankylosing\n             spondylitis), traumatic, or infective origins\n\n          -  Any condition, disease or concomitant treatment that in the judgement of the\n             Investigator will affect the subject's ability to participate in the clinical trial\n             or which will influence the test methodology used\n\n          -  Negative experience in the past with heat treatment for muscle complaints (e. g. hot\n             water bottle, heat pads, hyperemisation-inducing topical creams, ointments or\n             patches)\n\n          -  History of treatment of back pain with centrally acting analgesics (e. g. opioids)\n             and muscle relaxants\n\n          -  Surgery due to back pain or rehabilitation due to back pain in the last 12 months\n\n          -  Spinal injection back pain treatment within 6 months prior to enrollment\n\n          -  Intake of antidepressant/antipsychotic medication within 4 weeks prior to enrollment\n\n          -  Treatment of the recent low back pain period with oral analgesics for more than 4\n             consecutive days\n\n          -  Locally applied medication to the back within 48 hours prior to enrollment (topical\n             treatments, injections)\n\n          -  Administration of other analgesics within 24 h prior to enrollment (exception: acetyl\n             salicylic acid (ASS) up to 100 mg/daily for anti platelet-aggregation therapy)\n\n          -  Non-pharmacological low back pain treatment (physiotherapy, heat treatment (e.g. hot\n             water bottle, heat patch, or massages) within 12 h prior to enrollment\n\n          -  Participation in an investigational drug or device trial within 4 weeks prior to\n             enrollment\n\n          -  Hypersensitivity to Nicoboxil, Nonivamide, or paracetamol\n\n          -  Known hypersensitivity to any other ingredient, especially to sorbic acid/sorbate, to\n             citronella oil containing e.g. the fragrance compounds geraniol, citronellol and\n             citronellal, or to relevant flowers containing these compounds such as geranium,\n             lavender, jasmine or rose. For patients with known hypersensitivity to perfumes or\n             known type IV hypersensitivity to fragrance-mix I, the application of the\n             investigational product should be performed only with particular caution.\n\n          -  Skin lesions (e. g., rash, dermatitis, bruising, laceration) in the back region\n\n          -  Drug dependence and/or alcohol abuse\n\n          -  Severe hepatocellular insufficiency\n\n          -  Patients who are pregnant or breast-feeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "805", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 16, 2012", 
        "firstreceived_results_date": "April 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01708915", 
            "org_study_id": "69.52", 
            "secondary_id": "2011-003890-27"
        }, 
        "intervention": [
            {
                "arm_group_label": "nicoboxil", 
                "description": "2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period", 
                "intervention_name": "nicoboxil", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "placebo", 
                "description": "2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period", 
                "intervention_name": "placebo matching nonivamide + nicoboxil", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "nonivamide + nicoboxil (Finalgon)", 
                "description": "2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period", 
                "intervention_name": "nonivamide + nicoboxil (Finalgon)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "nonivamide", 
                "description": "2cm ointment line for a skin area of approximately 20 cm x 20 cm up to 3 times in a 24h period", 
                "intervention_name": "nonivamide", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Nonivamide", 
                "Capsaicin"
            ]
        }, 
        "lastchanged_date": "May 20, 2014", 
        "link": {
            "url": "http://trials.boehringer-ingelheim.com/content/dam/internet/opu/clinicaltrial/com_EN/results/69/69.52_U13-2315-01.pdf"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bad Lippspringe", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49007 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49003 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49004 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49041 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49033 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49026 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49032 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Einbeck", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49002 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Essen", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49036 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Essen", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49024 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Essen", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49031 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Everswinkel", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49005 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "F\u00fcrth", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49039 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Goch", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49018 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gro\u00dfheirath-Rossach", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49025 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Haag", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49022 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49009 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49019 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kaarst", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49015 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Karlsruhe-R\u00fcppurr", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49042 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "K\u00f6ln", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49040 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "K\u00f6ln", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49035 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "K\u00f6ln", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49027 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "K\u00f6then", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49013 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "K\u00fcnzing", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49014 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ludwigshafen", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49034 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Me\u00dfkirch", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49028 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Me\u00dfkirch", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49030 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "M\u00fcnster", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49029 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Neunkirchen", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49012 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rodgau", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49020 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Siegen", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49037 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockach", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49016 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stra\u00dfkirchen", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49010 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Villingen-Schwenningen", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49021 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wangen", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49023 Boehringer Ingelheim Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Weilburg", 
                        "country": "Germany"
                    }, 
                    "name": "69.52.49011 Boehringer Ingelheim Investigational Site"
                }
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Multi-centre, Double-blind, Randomised, Parallel Group Study to Assess the Efficacy and Safety of Multiple Doses of Topically Applied Hyperemisation-inducing Ointment (2cm Ointment Line Per Application; up to 3 Times Daily for up to 4 Days) Containing 2.5% Nicoboxil/0.4% Nonivamide Versus 2.5% Nicoboxil, 0.4% Nonivamide and Placebo in Patients 18 to 65 Years of Age With Acute Low Back Pain", 
        "overall_official": {
            "affiliation": "Boehringer Ingelheim", 
            "last_name": "Boehringer Ingelheim", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Pain intensity (PI) was assessed on a 11-point numerical rating scale ranging from 0 (no pain) to 10 (worst pain possible) at pre-dose baseline and 0.5, 1, 2, 3, 4, 6 and 8 hours after first ointment application. Means were adjusted for centre effect and baseline value.", 
            "measure": "Pain Intensity Difference (PID) Between Pre-dose Baseline and 8hours After First Application", 
            "safety_issue": "No", 
            "time_frame": "Baseline and 8 hours after first ointment application"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01708915"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Pain intensity was assessed on a 11-point numerical rating scale ranging from 0 (no pain) to 10 (worst pain possible) at pre-dose baseline and 0.5, 1, 2, 3 and 4 hours after first ointment application. Means were adjusted for centre effect and baseline value.", 
                "measure": "Pain Intensity Difference (PID) Between Pre-dose Baseline and 4 Hours After First Application", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 4 hours after first ointment application"
            }, 
            {
                "description": "Average pain intensity was assessed in the evening of days 1, 2, 3 and 4 on a 11-point numerical rating scale ranging from 0 (no pain) to 10 (worst pain possible). The last individual treatment day is the last day with diary-recorded ointment application. Means were adjusted for centre effect and baseline value.", 
                "measure": "Difference Between Baseline Pain Intensity and Average Pain Intensity on the Last Individual Treatment Day", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 1 to 4 days"
            }, 
            {
                "description": "Patient assessment of efficacy was assessed on a 4-point verbal rating scale (VRS, 0 = 'poor', 1 = 'fair', 2 = 'good', 3 = 'very good' relief of the patients' low back pain) in the evening of days 1, 2, 3 and 4. The last individual treatment day is the last day with diary-recorded ointment application", 
                "measure": "Patient Assessment of Efficacy on the Last Individual Treatment Day", 
                "safety_issue": "No", 
                "time_frame": "1 to 4 days"
            }
        ], 
        "source": "Boehringer Ingelheim", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Boehringer Ingelheim", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}